DSDavid Scherr

David Scherr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

David Scherr has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Ana Kanazir

    Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA

    1 shared publication
  • David Nellis

    Frederick Manufacturing Center, Manufacturing Sciences and Technology AstraZeneca Frederick Maryland USA

    1 shared publication
  • Jan Martinek

    Dynamic Omics, Center for Genomic Research, Biopharmaceutical Research and Development AstraZeneca Gaithersburg Maryland USA

    1 shared publication
  • Jon Coffman

    Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA

    1 shared publication
  • Michael Mollet

    Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA

    1 shared publication
  • Nikunj Sharda

    Bioprocess Technologies and Engineering, Biopharmaceutical Development AstraZeneca Gaithersburg Maryland USA

    1 shared publication

Latest Publications

  • Open Access

    10‐Fold Improvement in Depth Filter Capacity During Integrated Dynamic Bioprocessing (IDB) Purification Through Depth Filter Cycling and Precipitate Control Strategy

    by David Scherr, Ana Kanazir, Samik Das, Nikunj Sharda, Jan Martinek, David Nellis, Michael Mollet, Jon Coffman

    During bsAb1 purification, precipitate was formed during neutralization of the affinity capture product. This precipitate was removed before loading onto the first polishing column in the Integrated Dynamic Bioprocessing (IDB) platform. The precipitate had a dynamic particle size distribution that caused complex scaling without proper characterization. Herein, the study established a protocol for characterizing downstream precipitate formation and operating a depth filter (Emphaze AEX) like a chromatography column to support continuous purification of bsAb1. The depth filter is “underloaded” with precipitated material, followed by a chase step and the application of sanitization buffers. The sanitization buffers solubilized precipitate bound to the depth filter and controlled bioburden, drastically increasing the filter capacity and helped ensure a closed system. At the bench, the depth filter was cycled 40 times for a total capacity of 10,500 L/m 2 . This capacity is an order of magnitude greater than when the depth filter is loaded to max capacity without any cycling or sanitization. The resulting cycling capacity eases depth filter scale‐up and IDB implementation at the clinical and commercial scale.